• Assessment of Cost-Effectiveness Models for Biologics in the Management of Severe Ankylosing Spondylitis

    Nov 1, 2013, 00:00

  • Cost Effectiveness of Paliperidone Palmitate in National Health Service (NHS) Wales- A Cost Utility Analysis Based on the National Institute for Health and Care Excellence (NICE) Core Model for the Management of Schizophrenia

    Nov 1, 2013, 00:00

  • Skeletal-Related Events Have a Significant Impact on Health-Related Quality of Life in Men with Metastatic Castration Resistant Prostate Cancer (mCRPC) Following Docetaxel Therapy Failure

    Nov 1, 2013, 00:00

  • Handling Variability in Time Endpoints in Multi-Centre Time and Motion (TM) Studies- A Case Study of Erythropoiesis-Stimulating Agents for Anaemia Management in 13 Centres in Italy

    Nov 1, 2013, 00:00

  • Should There Be an Option to “Unrefer” Nice Single Technology Appraisals- Case Study of Aripiprazole for Bipolar I Disorder in Adolescents

    Nov 1, 2013, 00:00

  • Assessing Measurement Equivalence of Different Forms of Administration of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) Using Rasch Analysis

    Nov 1, 2013, 00:00

  • Respiratory Syncytial Virus Hospitalizations in the Canadian Registry for Synagis (CARESS)

    Nov 1, 2013, 00:00

  • Cost Effectiveness Analysis for the Use of Extended Release Quetiapine as Adjunctive Therapy in Mexican Adult Patients with Major Depressive Disorder Non-Responders to Antidepressant Treatment

    Nov 1, 2013, 00:00

  • The Association Between Severity of ‘Average’ Pain (NPRS) and the EQ-5D Index in Patients with Neuropathic Pain

    Nov 1, 2013, 00:00

  • Costo-Efectividad De Tres Estrategias Diagnosticas Para La Identificación De Infección Bacteriana Severa En Lactantes Febriles Sin Foco

    Nov 1, 2013, 00:00

  • A Disease Model of Metastatic Colorectal Cancer Including Multiple Treatment Lines

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Cysteamine in the Treatment of Patients with Cystinosis – a Rare Disease

    Nov 1, 2013, 00:00

  • Age and Gender Distribution of Outpatient Care Physiotherapy Services for Dorsopathia Diseases in Hungary

    Nov 1, 2013, 00:00

  • Value Chain Analysis for Cardiac Devices

    Nov 1, 2013, 00:00

  • Atopic Dermatitis- Evaluation of 2 Different Drug Related Managements

    Nov 1, 2013, 00:00

  • Costs of Pilot Programs Employing Allied Health Professionals Within the Centers for Population Health and Health Disparities

    Nov 1, 2013, 00:00

  • A Cost-Utility Analysis of Lighterlife Total as a Treatment for Obesity in the United Kingdom

    Nov 1, 2013, 00:00

  • There Is More to Decision Making Than Costs and Effects- Handling Practical Constraints in the Value of Information Framework

    Nov 1, 2013, 00:00

  • Guiding Principles for Effective Private Health Insurance in Emerging Markets

    Nov 1, 2013, 00:00

  • Treatment Satisfaction and Its Association with Health Outcomes in Patients with Neuropathic Pain

    Nov 1, 2013, 00:00

  • An Overview of Domestic Cancer Drugs in Turkey- 2008-2012

    Nov 1, 2013, 00:00

  • Symptoms of COPD in Urban Russia Among Adults 40 Years and Older

    Nov 1, 2013, 00:00

  • Validación De Un Cuestionario Para Medir Riesgo De Cáncer De Piel

    Nov 1, 2013, 00:00

  • Economic Evaluation of Ceftobiprole Compared to a Combination of Linezolid with Ceftazidime in the Management of Hospitalised Pneunomia in Scotland

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Study of Nutrition Support (NS) Usage During Intensive Treatment

    Nov 1, 2013, 00:00

  • The Estimated Survival of Patients with Double Refractory Chronic Lymphocytic Leukaemia; A Reanalysis of NICE TA202 Using Bayesian Methodology to Model Observed Data

    Nov 1, 2013, 00:00

  • Treatment Patterns of Ranibizumab and Aflibercept for the Management of Wet Age-Related Macular Degeneration in Routine Clinical Practice in the United States

    Nov 1, 2013, 00:00

  • Risk Factors for Discontinuation of Insulin Pump Therapy in Pediatric and Young Adult Patient Groups

    Nov 1, 2013, 00:00

  • Adrenal Insufficiency- Burden of Disease and Cost of Illness

    Nov 1, 2013, 00:00

  • WITHDRAWN

    Nov 1, 2013, 00:00

  • Assessing the Economic Burden and Health Care Utilizations of Veteran Patients Diagnosed with Chronic Kidney Disease in the United States

    Nov 1, 2013, 00:00

  • Linguistic Translation and Cultural Adaptation of Functional Assessment of Chronic Illness Therapy-Tuberculosis Instrument into Arabic Language

    Nov 1, 2013, 00:00

  • A Comparison of Demographic and Clinical Variables of Down Syndrome Patients in Utah and the United States

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Dapagliflozin (Forxiga®) Versus a DPP-4 Inhibitor in the Treatment of Type 2 Diabetes Mellitus (T2DM) in England and Wales

    Nov 1, 2013, 00:00

  • Costs of Primary Biliary Cirrhosis Treatment with Ursodeoxycholic Acid in Brazil

    Nov 1, 2013, 00:00

  • Multiple Imputation Techniques for Survey Data with Multiple Rating Scales

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Dapagliflozin (Forxiga®) Versus Glipizide in the Treatment of Type 2 Diabetes Mellitus (T2DM) in England and Wales

    Nov 1, 2013, 00:00

  • Benefit of Adding Panitumumab to FOLFOX4 in Patients with KRAS/NRAS Wild-Type (WT) Metastatic Colorectal Cancer (mCRC)- A Number-Needed-To-Treat (NNT) Analysis

    Nov 1, 2013, 00:00

  • Budget Impact of Metastatic Castrate-Resistant Prostate Cancer (CRPC) to German Payers

    Nov 1, 2013, 00:00

  • Health Economic (HE) Data Requirements and Availability in the European Union. Results of a Survey

    Nov 1, 2013, 00:00

  • Hemangioma Family Burden- Creation of a Specific Questionnaire

    Nov 1, 2013, 00:00

  • Two-Way Sensitivity Analysis- Showing the Impact of Correlated Parameters in Cost-Effectiveness Analyses

    Nov 1, 2013, 00:00

  • Economic Evaluations of Varicella and Herpes Zoster Vaccination Programmes- A Systematic Review

    Nov 1, 2013, 00:00

  • Pet-Based Radiotherapy Treatment Planning Is Highly Cost-Effective Compared to CT-Based Planning- A Model-Based Evaluation

    Nov 1, 2013, 00:00

  • The Diabetic Peripheral Neuropathic Pain Impact (DPNPI) Measure – Psychometric Validation of a New Patient Reported Outcome Measure

    Nov 1, 2013, 00:00

  • Length of Stay and Outcomes for Adolescents Treated for Substance Use Disorder- An Analysis of Dose Respose Using Propensity Scores

    Nov 1, 2013, 00:00

  • Evaluating Willingness-To-Pay Threshold for Sugammadex Reversal of Rocuronium-Induced Neuromuscular Blockade- A Contingent Valuation Survey

    Nov 1, 2013, 00:00

  • Budget Impact of an Individualized Approach in the Treatment of HBeAg-Negative CHB Patients Exploiting the Week-12 Peginterferon Alfa-2a Stopping Rule in Italy

    Nov 1, 2013, 00:00

  • Patient Preferences and Priorities for Anti-Epileptic Drug Treatment

    Nov 1, 2013, 00:00

  • Validity of QOL Impact Attributions to Specific Diseases- A Multitrait-Multimethod Comparison

    Nov 1, 2013, 00:00

  • Review of Nice Technology Appraisals in Oncology- How Does Clinical Evidence Change Over Time?

    Nov 1, 2013, 00:00

  • Adjusting for Treatment Switching in Clinical Trials When Only Summary Data Are Available – An Evaluation of Potential Methods

    Nov 1, 2013, 00:00

  • Perception of Users of Drug Distribution Program in Brazil

    Nov 1, 2013, 00:00

  • Adherence to Antiretroviral Therapy Among HIV-Infected Patients Attending to a University Infectious Diseases Clinic in Venezuela

    Nov 1, 2013, 00:00

  • Conditional Survival (CS) Probabilities for Advanced Melanoma Patients Treated with Ipilimumab- Model Based Analysis

    Nov 1, 2013, 00:00

  • Perfil De Adesão Aos Planos De Benefício Em Medicamentos

    Nov 1, 2013, 00:00

  • Costo-Efectividad Del Trasplante Renal Comparado Con La Diálisis En Colombia

    Nov 1, 2013, 00:00

  • Value Judgments in Health Technology Assessment Process in Brazil

    Nov 1, 2013, 00:00

  • Validation of the Multiple Sclerosis International Quality of Life Questionnaire in Electronic Form Using Item Response Theory

    Nov 1, 2013, 00:00

  • Diffusion of the Efficiency Frontier Approach Within Health Economic Evaluation- Current and Future Applications

    Nov 1, 2013, 00:00

  • Impacto De La Diabetes Sobre La Productividad En Argentina

    Nov 1, 2013, 00:00

  • A Parent-Administered But Child-Completed Patient-Reported Outcome (PRO) Provides a Measure with Content Validity That Is Valid and Reliable for Use in Children Aged 6 to 11 Years

    Nov 1, 2013, 00:00

  • The Impact of Amnog on Drug Reimbursement in Germany

    Nov 1, 2013, 00:00

  • Investing in European Health RD – A Pathway to Sustained Innovation and Stronger Economies

    Nov 1, 2013, 00:00

  • A Budget Impact Analysis to Estimate the Economic Impact of Drug Eluting Balloon for the Treatment of Peripheral Vascular Disease

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of a New Fixed-Dose Combination Inhaler for a Clinical Commissioning Group within the National Health Service in England

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis-C Virus Infection in Venezuela

    Nov 1, 2013, 00:00

  • Different Discounting Approaches and Their Impact in Economic Evaluation- A Practical Example Using Hepatitis B Vaccination

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Insulin Detemir in T2DM Patients Poorly Controlled with NPH Insulin in Poland

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad Del Uso De Estatinas En La Prevención De Eventos Cardiovasculares En Colombia

    Nov 1, 2013, 00:00

  • How to Determine Size of Patient Population When the Right Data Isn’t There?

    Nov 1, 2013, 00:00

  • Lifetime Cost-Effectiveness of Concomitant Aortic Valve Replacements in France and the United Kingdom

    Nov 1, 2013, 00:00

  • Efficacy of Long-Acting Injectable Antipsychotic Therapies in Maintenance Treatment of Schizophrenia- A Mixed Treatment Comparison (MTC) of Double-Blind Randomized Clinical Trials

    Nov 1, 2013, 00:00

  • Parental Preferences for Rotavirus Vaccination and Potential Vaccination Coveragein Young Children- A Discrete Choice Experiment

    Nov 1, 2013, 00:00

  • Costs of Hormonal Receptor Positive, Her 2 Negative Metastatic Breast Cancer (MBC-HR+) in Brazilian Private System (BPS)- A Real World and Published Literature Analysis

    Nov 1, 2013, 00:00

  • Economic Evaluation of Liraglutide for Treatment of Type 2 Diabetes Mellitus in the Russian Federation

    Nov 1, 2013, 00:00

  • Scoring the Center for Epidemiologic Studies – Depression Scale- Which Items Go Where?

    Nov 1, 2013, 00:00

  • Análisis Costo-Utilidad De Dos Alternativas Para El Tratamiento De Bebés Prematuros En Bogotá

    Nov 1, 2013, 00:00

  • Assessment of the Key Drivers of Cost-Effectiveness in the Economic Modelling of Canagliflozin (CANA) Versus Glimepiride (GLIM) in the Treatment of Type 2 Diabetes Mellitus (T2DM) in the UK Setting

    Nov 1, 2013, 00:00

  • Quality Assessment of Observational Studies for Systematic Reviews

    Nov 1, 2013, 00:00

  • Clinical Benefits of Immunosuppression Therapy in Renal Trasplant Patients. Systematic Review and Meta-Analysis

    Nov 1, 2013, 00:00

  • Mapping the Oxford Hip Score (OHS) to EQ-5D- A Test of Model Performance

    Nov 1, 2013, 00:00

  • The Volume-Outcome Relationship and Minimum Volume Standards – Empirical Evidence for Germany

    Nov 1, 2013, 00:00

  • Differences in the Weighted Average Daily Doses of Statins in Latin America and Their Potential Impact on Cardiovascular Outcomes

    Nov 1, 2013, 00:00

  • A Comparison of German Benefit Assessments by G-Ba, IQWiG and Manufacturers

    Nov 1, 2013, 00:00

  • Economic Evaluation of an Electrical Impedance Spectroscopy (EIS) Device Used as an Adjunct to Colposcopy

    Nov 1, 2013, 00:00

  • Indirect Costs of Systemic Lupus Erythematosus-Related Absenteeism in Poland- An Analysis Based on Social Insurance Institution Data

    Nov 1, 2013, 00:00

  • Economic Evaluation of Fulvestrant 500 Mg Versus Generic Non-Steroidal Aromatase Inhibitors in Patients with Advanced Breast Cancer in Norway

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Sapropterin Versus Phenylalanine Free Diet in Patients with Phenylketonuria in Egypt

    Nov 1, 2013, 00:00

  • Comparing the Health Care Costs and Utilizations Between Patients with Anxiety Versus Those Without

    Nov 1, 2013, 00:00

  • Health Related Quality of Life of Patients with Bladder Cancer in Hungary

    Nov 1, 2013, 00:00

  • The 2013 Revision to Nice’s Discounting Guidelines- Differential Discounting Has Gone But Unjustified Selective Application Remains

    Nov 1, 2013, 00:00

  • Análisis De Costo Efectividad De Acido Gadoterico Frente a Otros Medios De Contrastes Basados En Gadolinio

    Nov 1, 2013, 00:00

  • Instructions for Authors

    Nov 1, 2013, 00:00

  • Health Care Resource Utilization and Costs Associated with Treatment of Polish Acromegalic Patients with Lanreotide Autogel 120 Mg – A Retrospective Observational Cohort Analysis

    Nov 1, 2013, 00:00

  • Assessment of Real-World Usage of Lanreotide (Somatuline Autogel) 120 Mg in Polish Acromegalic Patients – Results from 1 Year Prospective Phase of Lanro-Study

    Nov 1, 2013, 00:00

  • ‘Big Data’ in Health Care. What Does It Mean and Will It Make a Difference?

    Nov 1, 2013, 00:00

  • The Efficiency of Preoperative Physiotherapy in Patients with Chronic Obstructive Pulmonary Disease Undergoing Open Heart Surgery

    Nov 1, 2013, 00:00

  • Head to Head Economic Evaluation of Two Genomic Profiles of Recurrence Risk for Breast Cancer, Mammaprint Versus Oncotype DX, in Spain

    Nov 1, 2013, 00:00

  • Cross-Country Comparison of Prescribing Patterns Versus Portugal and Potential Cost-Savings

    Nov 1, 2013, 00:00

  • Uso De Bases De Datos O Sistemas De Información Para Soportar La Toma De Decisiones En Salud En Colombia

    Nov 1, 2013, 00:00

  • Acceptability of Indirect Evidence to Support Drug Reimbursement in Australia

    Nov 1, 2013, 00:00

  • Structural Validation of the Chronic Venous Insufficiency Quality of Life Questionnaire-14 (CIVIQ-14) - A Confirmatory Factor Analysis

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad De Las Vacunas Neumocócicas 13-Valente Y 23-Valente Para Adultos De Alto Riesgo En Colombia

    Nov 1, 2013, 00:00

  • Patient Preference for Oral Versus Injectable and Intravenous Methods of Treatment for Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • The Role of Communication and Health Literacy on Patient Safety in Public Pharmacies in the Republic of Srpska

    Nov 1, 2013, 00:00

  • Estimación De La Costo-Efectivadad Del Uso De Daptomicina Vs Vancomicina En Pacientes Con Bacteriemia Y/O Endocarditis Por S. Aureus Resistente a Meticilina

    Nov 1, 2013, 00:00

  • Factors Related to Adherence After a Multifactorial Intervention to Improve It in Patients with Chronic Obstructive Pulmonary Disease (COPD). Icepoc Study

    Nov 1, 2013, 00:00

  • Variations in Treatment Patterns and Disease Severity Among Patients with Psoriasis Receiving Their First Biologic in European Union

    Nov 1, 2013, 00:00

  • The Burden of Caregiving in Cancer- The Status of Clinical Research

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Dapaglifozin Versus Other T2DM Treatments in the Spanish Context

    Nov 1, 2013, 00:00

  • The Association Between European Medicines Agency Approval and Health Technology Assessment Recommendation

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Catheter Ablation as First-Line Treatment

    Nov 1, 2013, 00:00

  • Treatment Patterns of Indolent Non-Hodgkin Lymphoma Patients Under the Brazilian Public Health Care Perspective

    Nov 1, 2013, 00:00

  • Interruption/Bridging of VKA Treatment of Patients with Atrial Fibrillation- Analysis of Incidence and Clinical Outcomes Based on a German Claims Based Data Set

    Nov 1, 2013, 00:00

  • Calidad De Prescripción De Antibióticos En El Servicio De Pediatria De Un Hospital General De Cardenas, Tabasco, México

    Nov 1, 2013, 00:00

  • Update on Pharmacoeconomics in Nutrition- Parenteral Glutamine Supplement in Intensive Care Unit Patients

    Nov 1, 2013, 00:00

  • Health-Economic Comparison of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections for the Treatment of Type 1 Diabetes in Kazakhstan Children

    Nov 1, 2013, 00:00

  • Estimating Prevalence of Prostate Cancer Clinical States Using a Dynamic Patient Progression Model

    Nov 1, 2013, 00:00

  • Correlation Between Montgomery-Asberg Depression Rating Scale (MADRS) and the Beck Depression Inventory II (BDI-II) in Patients with Focal Epilepsy

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Paliperidone Palmitate for the Treatment of Schizophrenia in Germany

    Nov 1, 2013, 00:00

  • Cost Effectiveness of Anti-Oxidant Vitamin + Zinc Treatment to Prevent the Progression of Intermediate Age Related Macular Degeneration to Its Wet Form. A Singapore Perspective

    Nov 1, 2013, 00:00

  • Comparison of Drug Assessments in France, Germany and the United Kingdom- Is European HTA a Reality?

    Nov 1, 2013, 00:00

  • A Review of Cognitive Interviewing Methodologies During Linguistic Validation of Clinical Outcome Assessments (COAs)

    Nov 1, 2013, 00:00

  • Análisis Costo-Efectividad De Linezolid Comparado Con Vancomicina En El Manejo De La Neumonía Asociada A La Ventilación Mecanica En Colombia

    Nov 1, 2013, 00:00

  • Indirect Comparisons of Novel Oral Anticoagulants for the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation- A Systematic Literature Review

    Nov 1, 2013, 00:00

  • Eficácia E Segurança De Ranibizumabe E Bevacizumabe No Tratamento De Degeneração Macular Relacionada a Idade

    Nov 1, 2013, 00:00

  • EQ-5D-5L Crosswalk Value Set for Poland

    Nov 1, 2013, 00:00

  • Constructing an Index of International Pharmaceutical Prices. A Comparison of Pharmaceutical Prices in 56 Countries

    Nov 1, 2013, 00:00

  • Racial Disparities in Diffusion, Comparative Morbidity, and Disease Control of Intensity-Modulated Radiation Therapy Compared to Conformal Radiation Therapy for Localized Prostate Cancer

    Nov 1, 2013, 00:00

  • Costs Associated with the Impact of Progressive Multiple Sclerosis- Insights from a Three Year Clinical Trial (The Cupid Trial)

    Nov 1, 2013, 00:00

  • Pre-Financing Function of the Pharmaceutical Full-Line Wholesale Sector in the European Union

    Nov 1, 2013, 00:00

  • Estudios Del Coste De La Enfermedad

    Nov 1, 2013, 00:00

  • DETERMINING THE MAGNITUDE OF A DETECTABLE AND A RELEVANT TREATMENT BENEFIT IN AESTHETIC MEDICINE USING A PHOTOGUIDE AND THE INTERNET

    Nov 1, 2013, 00:00

  • How University Hospital of Crete Succeeded in Decreasing Cytostatics’ Budget in 2012?

    Nov 1, 2013, 00:00

  • Therapy Escalation Thresholds and the Potential for Biased Cost Effectiveness Analysis When Failing to Sample Baseline HbA1c in Type 2 Diabetes

    Nov 1, 2013, 00:00

  • Inhaled Corticosteroids (ICS) in Treatment of Moderate and Severe Asthma in Russian Federation – Comparative Pharmacoeconomic Study

    Nov 1, 2013, 00:00

  • Systematic Review on Use of Economic Evidence by Clinical Guidelines

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Assessment of Ranibizumab in the Treatment of the Diabetic Retinopathy in the Russian Federation

    Nov 1, 2013, 00:00

  • Overview on Cost-Effectiveness Results of Decision-Analytic Studies for the Treatment of Multiple Myeloma

    Nov 1, 2013, 00:00

  • Correlation Between Prognostic Factors and Non Prosthetic Further Fracture Related Treatment After Femoral Neck Fracture Underwent Internal Fixation in Elderly

    Nov 1, 2013, 00:00

  • The Presence of Metabolic and Other Risk Factors in Adrenal Insufficiency Patients Compared to an Unmatched Background Population from the Same Region in the United Kingdom

    Nov 1, 2013, 00:00

  • Statins in Canada- The Case for Disinvestment

    Nov 1, 2013, 00:00

  • Chemotherapy Treatment Patterns, Health Care Costs, and Mortality of Lung Cancer Patients in Taiwan – A Longitudinal Study Between 2000 and 2008

    Nov 1, 2013, 00:00

  • Comparative Effectiveness of Liraglutide Versus Sitagliptin in Type 2 Diabetes in the United Kingdom- A Retrospective Study in Primary Care

    Nov 1, 2013, 00:00

  • Relevance of Indirect Comparisons in the German Early Benefit Assessment (AMNOG)

    Nov 1, 2013, 00:00

  • Do EMA and FDA Have Different Opinions/Requirements in Terms of Pediatric Studies for Sitagliptin (Alone or in Combination)?

    Nov 1, 2013, 00:00

  • Variances in Individuals’ Prescription Drug Costs in Ireland

    Nov 1, 2013, 00:00

  • Comparisons of the Clinical Effectiveness of Treatments for the Symptoms Associated with Overactive Bladder (OAB)

    Nov 1, 2013, 00:00

  • Permanent Transvenous Lead Extraction- Factors Influencing the Difficulty of the Procedure

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Telaprevir Plus Peginterferon/Ribavirin (TVR+PR) Versus Peginterferon/Ribavirin (PR) in Treatment-Naïve Genotype 1 Chronic Hepatitis C Patients with F2 Fibrosis in Brazil

    Nov 1, 2013, 00:00

  • Additional Clinical Benefit for Patient Relevant Endpoints- Investment Disincentives by AMNOG in the Example of Parkinson’s Disease

    Nov 1, 2013, 00:00

  • What Are the Clinical and Economic Costs and Benefits of Implementing Point of Care Tests for Chlamydia Trachomatis and Neisseria Gonorrhoea in Genito-Urinary Medicine Clinics in the United Kingdom?

    Nov 1, 2013, 00:00

  • A Cost-Effectiveness Model Comparing Sub-Cutaneous Biologic Treatment for Severe Plaque Psoriasis in Mexico

    Nov 1, 2013, 00:00

  • Economic Evaluation of Fluoroquinolone-Based Regimens for the Treatment of Community-Acquired Pneumonia in a Multi-Field Hospital in Russia

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Deferasirox in the Treatment of Non Transfusion Dependent Thalassemia in Greece

    Nov 1, 2013, 00:00

  • Cost-Utility Analyses of Cognitive-Behavioral Therapy for Major Depressive Disorder – A Systematic Review

    Nov 1, 2013, 00:00

  • Impact of Dosage and Seven Other Factors in the Adherence to Oral Medication in People with Diabetes Type 2 in Germany

    Nov 1, 2013, 00:00

  • Societal Unmet Needs in Brazil- Examining Prevalence, Treatment Rates, and Health Outcomes

    Nov 1, 2013, 00:00

  • Are “Dizzy” and “Lightheaded” the Same Concept or Separate Concepts? Challenges in Conceptual Equivalence of These Terms in 20 Languages

    Nov 1, 2013, 00:00

  • Assessing the Future Burden of Renal Replacement Therapy in the United Kingdom

    Nov 1, 2013, 00:00

  • Work Productivity Loss Due to Rheumatoid Arthritis in Poland. Results of Cross-Sectional Study of Outpatients with Chronic Inflammatory Diseases and Comparison with Selected Studies

    Nov 1, 2013, 00:00

  • ESTIMATED COSTS OF HER2-POSITIVE METASTATIC BREAST CANCER FOR PATIENTS INITIATING AN ORAL ANTICANCER TREATMENT- RESULTS FROM A FRENCH PROSPECTIVE OBSERVATIONAL STUDY

    Nov 1, 2013, 00:00

  • Patient Preferences on Treatments for Erectil Dysfunction Defined by Means of Different Attribute Groups- The Method of Administration Is the Most Valued Attribute and the Orodispersible Tablet Is the Most Preferred Level

    Nov 1, 2013, 00:00

  • Impact of Switching on Health Care Costs and Outcomes in Generic Drug Policies

    Nov 1, 2013, 00:00

  • Assessment and Causal Link Between Vision-Related Quality of Life and General Health Related Quality of Life in Dry Eye Patients

    Nov 1, 2013, 00:00

  • Tocilizumab in Polyarticular Juvenile Idiopathic Arthritis – A Cost-Utility Model for the United Kingdom

    Nov 1, 2013, 00:00

  • The Nice Medical Technology Evaluation Programme (MTEP) – Insights for Manufacturers Considering Notification

    Nov 1, 2013, 00:00

  • Safety in National Care - Real World Data from the German Psoriasis-Registry “Psobest”

    Nov 1, 2013, 00:00

  • Illustration of the Combined Effect of Patient’s Adherence and Individual Biological Characteristics on Blood Pressure

    Nov 1, 2013, 00:00

  • Quality of Life in Patients with Gastroesophageal Reflux Disease in Slovakia

    Nov 1, 2013, 00:00

  • Budget Impact of Switching Pramipexole Immediate Release to Pramipexole Extended Release in Treatment of Parkinson’s Disease; Perspective of the Social Security Institution

    Nov 1, 2013, 00:00

  • Attitudes of Physicians Toward Implementing Shared Medical Appointments at National Guard Family Medicine Centers in Riyadh

    Nov 1, 2013, 00:00

  • Factors Associated with Early Response to Olanzapine and Clinical and Functional Outcomes of Early Responders Treated for Schizophrenia in China

    Nov 1, 2013, 00:00

  • Total Costs and Outcomes of Drug-Eluting Stent Placement with Intravascular Ultrasound (IVUS) Compared with Angiography Alone- A Cost-Effectiveness Analysis from the Perspective of the Italian Health System

    Nov 1, 2013, 00:00

  • Examining the Burden of Illness of Veteran Patients with Prostate Cancer in the United States

    Nov 1, 2013, 00:00

  • Physician Panels Supporting Clinical Trials and Post-Approval Studies in Oncology- A Willingness-To-Participate Study

    Nov 1, 2013, 00:00

  • Quality of Life in Patients with Venous Thromboemoblism- A Systematic Literature Review

    Nov 1, 2013, 00:00

  • Extrapolating Survival in a Heterogeneous Patient Population with Metastatic Melanoma; A Case Study of Integrating Statistical and Clinical Consideration

    Nov 1, 2013, 00:00

  • Impact of Value Communication in Decision Making- An Approach to the Treatment of Type 2 Diabetes in Portugal

    Nov 1, 2013, 00:00

  • A Non-Interventional Retrospective Evaluation of Resources Consumed During the Provision of Care for Overactive Bladder Syndrome- A Real World Evaluation- German Perspective (The Reduce Study)

    Nov 1, 2013, 00:00

  • Health Care Resource Utilization and Cost Among Natalizumab Initiators with Multiple Sclerosis in the United States

    Nov 1, 2013, 00:00

  • A Bayesian Multiple Treatment Comparison of Duloxetine, Pregabalin, Gabapentin, Amitriptyline, and Their Combinations for Painful Peripheral Neuropathy Based on Pain Reduction Reported in Clinical Trails

    Nov 1, 2013, 00:00

  • Screen or Not to Screen for Peripheral Arterial Disease- Guidance from a Decision Model

    Nov 1, 2013, 00:00

  • Cost-Utility of Rheumatoid Arthritis Monotherapy with Tocilizumab in Spain

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Ivabradine Use in Belarus

    Nov 1, 2013, 00:00

  • The Relationship Between COPD Assessment Test (CAT) and EQ-5D in a Real World Patient Population

    Nov 1, 2013, 00:00

  • A Systematic Review of Cost-Of-Illness Studies and Cost-Effectiveness Analyses in Borderline Personality Disorder

    Nov 1, 2013, 00:00

  • The Efficacy of the Extra Front Loading Smoking Cessation Counselling Sessions on the Abstinence Rate Compared with Usual Care Used in Quit Smoking Clinic in Penang, Malaysia

    Nov 1, 2013, 00:00

  • Comparación Del Trabajo En Equipo En Salas De Cirugía Entre Un Hospital Privado Y Uno Público De Bogotá, D.C

    Nov 1, 2013, 00:00

  • Potential Financial Impact of Sugammadex in Anaesthetic Departments- A Budget Impact Analysis on Potentially Short Procedures Requiring Neuromuscolar Blockade

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Lisdexamfetamine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in the United Kingdom

    Nov 1, 2013, 00:00

  • Patient Networks as a Data Source for Patient Reported Outcomes Research. Carenity Experience

    Nov 1, 2013, 00:00

  • Medical Cards During Recession- How Many, for Whom and How Much?

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Somatropin Administration with Increased Adherence Due to Monitoring Compared to Non-Monitored Administration in Patients with Growth Hormone Deficiency

    Nov 1, 2013, 00:00

  • Epidemiology for Oncological Drugs Regarding the Benefit Dossier Preparation in Germany

    Nov 1, 2013, 00:00

  • Correlación Entre Los Niveles De LDL-C Frente Al Riesgo De Presentación De Evento Cardiovascular

    Nov 1, 2013, 00:00

  • Treatment Adherence and Costs in Multiple Sclerosis- A Narrative Review of the Literature

    Nov 1, 2013, 00:00

  • The Expanding Scope of Comparative Effectiveness Reviews Requires Collaborative Information Systems Solutions

    Nov 1, 2013, 00:00

  • Self-Monitoring of Blood Glucose with Insulin Analogues- Nice to Have or Need to Have? Analysis of Phase III Registration Trials and European Public Assessment Reports of Insulin Analogues

    Nov 1, 2013, 00:00

  • Costs of Best Supportive Care in the Treatment of Moderate-To-Severe Psoriasis in the United States

    Nov 1, 2013, 00:00

  • Physicians’ Preferences for Bone Metastases Treatments in the United States

    Nov 1, 2013, 00:00

  • Análise Das Potencialidades De Custo-Minimização Através Da Determinação Do Market Share Entre Os Quimioterápicos De Referência Que Possuem Genéricos Cadastrados Em Uma Operadora De Plano De Saúde

    Nov 1, 2013, 00:00

  • Efecto Del Seguro Popular Salud Sobre La Demanda De Servicios Prenatales En El Contexto De La Cobertura Universal, México 2012

    Nov 1, 2013, 00:00

  • Costo-Utilidad De Colágena-Polivinilpirrolidona En El Tratamiento De Osteartrosis De Rodilla I-Ii Frente Al Cuidado Estandar Establecido En Los Protocolos Vigentes De Las Instituciones Publicas En México

    Nov 1, 2013, 00:00

  • Health Technology Assessment of Contrast-Enhanced Ultrasound (CEUS) Techniques

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Periodic Safety Update Reports (PSURS) for Biologicals in Europe

    Nov 1, 2013, 00:00

  • Troika in Portugal- Pharmaceutical Sector from Paper to Reality

    Nov 1, 2013, 00:00

  • Burden of Infusion-Related Costs and Staff Time for Rheumatoid Arthritis in the Hospital Setting

    Nov 1, 2013, 00:00

  • The Impact of the Blind Bid Procedure in Hungary

    Nov 1, 2013, 00:00

  • Systematic Literature Review and Validity Evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in Patients with Multiple Sclerosis

    Nov 1, 2013, 00:00

  • Prevention of Gram-Positive Infections in Peritoneal Dialysis Patients – A Cost-Effectiveness Analysis

    Nov 1, 2013, 00:00

  • Patients at the Center of Regulatory Decisions- Using Stated-Preference Data to Help Regulators Answer Difficult Questions

    Nov 1, 2013, 00:00

  • How Does the Uncertainty Around the Expected ICER Affect Nice Decisions?

    Nov 1, 2013, 00:00

  • Addressing Childhood-Obesity in Mexico- Savings on Health Care Expenditures from Regulating Food and Beverage Sales in Basic Education Schools

    Nov 1, 2013, 00:00

  • Benefits of Vildagliptin Plus Metformin Combination Therapy in Type 2 Diabetes Mellitus (T2DM) from Patient’s Perspective- Quality of Life (QoL) and Hypoglycemia Burden Analysis

    Nov 1, 2013, 00:00

  • The Budget Impact of Introducing Ranibizumab in England and Wales for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia

    Nov 1, 2013, 00:00

  • Clinical and Cost-effectiveness of a Procalcitonin Test as a Prompt Indicator of Prodomol Meningococcal Disease in Febrile Children- Cost-effectiveness Analysis

    Nov 1, 2013, 00:00

  • Evaluation of the Potential Efficacy of Ivabradine in Health Care of the Republic of Belarus

    Nov 1, 2013, 00:00

  • Diferencias En La Consecución De Información Sobre Costos Del Manejo De La Diabetes Mellitus En Colombia

    Nov 1, 2013, 00:00

  • Cost-Utility Analyses of Natalizumab Versus Interferon Beta-1a 44 Mcg for Rapidly Evolving Severe Relapsing-Remitting Multiple Sclerosis (RESRRMS) Patients in Brazil

    Nov 1, 2013, 00:00

  • The Impact of Daytime and Nocturnal Non-Severe Hypoglycaemic Events on People with Diabetes in Brazil

    Nov 1, 2013, 00:00

  • Analysis and Classification of Risk-Sharing Schemes Proposed in Reimbursement Application Received by AHTAPol in 2012

    Nov 1, 2013, 00:00

  • The Influence of HAQ Utility Mapping Algorithms on the Cost-Effectiveness of Second Line Biologics for Treatment of Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Trends in Hospital Admissions Among Men and Women Above the Age of 60 Living in Stockholm and Uppsala Counties in Sweden

    Nov 1, 2013, 00:00

  • Systematic Literature Review and Cost-effectiveness Analysis of Fetal Fibronectin Test for Predicting Preterm in Brazil

    Nov 1, 2013, 00:00

  • Efficacy and Safety of Agomelatine in Depressed Thai Patients Including the Elderly Depressed Population

    Nov 1, 2013, 00:00

  • Dabigatran Etexilate in Prevention of Stroke for Nonvalvular Atrial Fibrillation Patients in Turkish Health Care Setting; A Study on Cost Containment of Social Security Institution (SSI)

    Nov 1, 2013, 00:00

  • Who Knows Better? A Knowledge, Attitude and Practice Survey of Osteoporosis Prescreening Tools Among Pharmacists and Physicians

    Nov 1, 2013, 00:00

  • UTILITIES FOR TYPE 2 DIABETES MELLITUS AND ASSOCIATED COMPLICATIONS

    Nov 1, 2013, 00:00

  • A Cost-Consequence Analysis of Different Protease Inhibitors Schemes for HIV Treatment from the Colombian Health Care System Perspective

    Nov 1, 2013, 00:00

  • Canadian Burden of Choroidal Neovascularization Secondary to Pathologic Myopia- Baseline Characteristics of Patients

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Glycopyrronium Compared to Tiotropium in COPD Patients from a Swedish Societal Perspective

    Nov 1, 2013, 00:00

  • An Approach for Quantification of Patient Advocacy Group Input in the HTA Process

    Nov 1, 2013, 00:00

  • Modelling the Adenoma and Serrated Pathway to Colorectal Cancer (ASCCA)

    Nov 1, 2013, 00:00

  • Cost-Minimization Analysis of Maraviroc Versus Darunavir Raltegravir and Enfuvirtide for CCR5-Tropic Treatment-Experienced Patients with HIV Infection in Russia

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Cobas® EGFR Mutation Test Versus Sanger Sequencing in the Treatment of Locally Advanced or Metastatic NSCLC- A Payer Perspective in the United Kingdom

    Nov 1, 2013, 00:00

  • Preference Structure of Clinicians in the Use of Electronic Medical Records; Quantifying the Relative Importance of Barriers and Facilitators of an Innovation

    Nov 1, 2013, 00:00

  • Clinical Guidelines Evidence as a Criterion for Changes in the Legislation Combating Tuberculosis

    Nov 1, 2013, 00:00

  • Tratamento Do Câncer Colorretal Metastático Com Bevacizumabe E Cetuximabe- Acesso E Impacto Econômico Em Um Hospital Universitário

    Nov 1, 2013, 00:00

  • Profile of Back Pain Sufferers Across 5EU Countries

    Nov 1, 2013, 00:00

  • The New Italian Health Care Reform- Introducing New Measures to Speed Up Market Access

    Nov 1, 2013, 00:00

  • Assessing the Fiscal Consequences of Immunizing the Female and Male Population Against Human Papillomavirus (HPV) in Germany

    Nov 1, 2013, 00:00

  • Natalizumab for Rapidly Evolving Severe Relapsing-Remitting Multiple Sclerosis (RESRRMS) Patients- 5-Year Budget Impact Analysis (BIA) from the Brazilian Public Payer Perspective

    Nov 1, 2013, 00:00

  • Cost-effectiveness of Infant Pneumococcal Vaccination in the Netherlands

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness and Cost-Utility of Paliperidone Palmitate in the Treatment of Schizophrenia in Guatemala

    Nov 1, 2013, 00:00

  • Willingness to Pay (WTP) for a Brand Name Drug in Sâo Paulo, Brazil

    Nov 1, 2013, 00:00

  • Developing Realistic Pathways in Cost-Effectiveness Models for Psoriasis- What to Do When a Biologic Fails

    Nov 1, 2013, 00:00

  • Reducing the Length of Antibiotic Prophylaxis in Clinical Conditions

    Nov 1, 2013, 00:00

  • Quality of Life in Patients with Ostomy in Poland- Multicentre Cross-Sectional Study Using WHOQOL-BREF Questionnaire

    Nov 1, 2013, 00:00

  • Short-Term Disability (STD) Associated with Skeletal Related Events (SRES) in Commercially Insured Patients with Bone Metastases (BM) Secondary to Solid Tumors

    Nov 1, 2013, 00:00

  • Markov Models in Non Metastatic Prostate Cancer – Availability of Input Factors and Structurural Uncertainty

    Nov 1, 2013, 00:00

  • Analysing the Access to Priority Health Services in the Adolescent Population in Six Provinces in Northern Argentina

    Nov 1, 2013, 00:00

  • The Ecology of Medical Care in Poor Settings- Self Reported Health Care Utilization in Santiago Del Estero, Argentina

    Nov 1, 2013, 00:00

  • An Analysis of How Not to Use Cost-Effectiveness Analysis for Price-Setting

    Nov 1, 2013, 00:00

  • Eliciting the Relative Importance of Key Elements for Benefit-Risk Assessment- A Comparison Among General Population, Health Authority and Medical Doctors

    Nov 1, 2013, 00:00

  • Patient Eligibility and Use of Biologics in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis in the United States

    Nov 1, 2013, 00:00

  • Basic Attitude Towards Health Care Resource Allocation Decision Making in Japanese People -Utilitarianism or Egalitarianism?

    Nov 1, 2013, 00:00

  • Adherence Interventions to Improve Adherence to Antiretroviral Therapy in Low Income Settings- An Individual Patient Data Network Meta-Analysis

    Nov 1, 2013, 00:00

  • Cost of Obesity and Economic Value of Obesity Surgery for Turkey (CEVOS-T)

    Nov 1, 2013, 00:00

  • Costs Comparison of Cutaneous Drug Reactions Treatment Divided by Diagnosis Groups

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Comparison of Genotype 1 Hepatitis C Virus (HCV) Treatments Using Telaprevir (TVR) in Patients with Mild Fibrosis Versus Patients with Bridging Fibrosis and Cirrhosis

    Nov 1, 2013, 00:00

  • Multinational Consistency of a Discrete Choice Model in Quantifying Health States for the Extended 5-Level EQ-5D

    Nov 1, 2013, 00:00

  • Naturalistic Disease Management Study of Patients with Alcohol Dependence in the Primary Care Setting in the United Kingdom (STREAM)

    Nov 1, 2013, 00:00

  • Framework for Evidence Assessment Based on Grade and Application to HPV Vaccination in Males in the European Health Care Context

    Nov 1, 2013, 00:00

  • Economic Analysis of Protease Inhibitors in First-Line Haart in Adult Patients with HIV

    Nov 1, 2013, 00:00

  • Characteristics of Children and Adolescents Using Proton Pump Inhibitors or Histamine-2-Receptor Antagonists- Analysis of Thin and Pharmo Databases

    Nov 1, 2013, 00:00

  • Análisis Economico De La Profilaxis Secundaria Versus El Tratamiento a Demanda De Una Cohorte De Pacientes Colombianos Con Hemofilia a Y B Severa

    Nov 1, 2013, 00:00

  • Poder Popular Y Regulación Del Precio De Los Medicamentos En Venezuela

    Nov 1, 2013, 00:00

  • Real World Utilization of Biological Agents in Rheumatoid Arthritis Patients- A French National Claims Database Analysis Over the Period 2009-2011

    Nov 1, 2013, 00:00

  • Comparison of Clinical Characteristics of Patients with Rheumatoid Arthritis Receiving Their First Biologic and Biologic-Naïve Patients Considered Biologic-Suitable in the United States

    Nov 1, 2013, 00:00

  • Increased Risk of Cancer Incidence Associated with Repeat Medical Imaging- Designing Better Clinical Trial Protocols

    Nov 1, 2013, 00:00

  • Orphan Drugs in the German Early Benefit Assessment– Real World Versus G-Ba Bureaucracy

    Nov 1, 2013, 00:00

  • Budget Impact of the Introduction of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir, the First Integrase Inhibitor-Based Single Tablet Antiretroviral Regimen for HIV Treatment, to Third Party Payers in the United States

    Nov 1, 2013, 00:00

  • Are the Biotechnology and Pharmaceutical Sectors Defensive Relative to the SP 500?

    Nov 1, 2013, 00:00

  • Multivariate Network Meta-Analysis of Progression Free Survival and Overall Survival

    Nov 1, 2013, 00:00

  • Long-Term Benefits Over More Than 4 Years of Certolizumab Pegol Combination Therapy on Workplace and Household Productivity, and Participation in Social Activities in Rheumatoid Arthritis- Results from the Open-Label Extension Study of Rapi ...

    Nov 1, 2013, 00:00

  • Resources Saved by the Introduction of Day Surgery in the Greek National Health System

    Nov 1, 2013, 00:00

  • Clinical Effectiveness of Lacosamide and Its Impact on Concomitant Antiepileptic Drugs Consumption in the Czech Republic

    Nov 1, 2013, 00:00

  • Resource Use of Non-Small Cell Lung Cancer in Slovakia

    Nov 1, 2013, 00:00

  • Evaluating Patient Adherence Rates to Approved Disease Modifying Therapies (DMT) for Relapsing-Remitting Ms (RRMS)- Operational Setup for a Multi-Country, Multi-Center Study

    Nov 1, 2013, 00:00

  • Health Economic Analyses in Medical Nutrition- A Systematic Literature Review

    Nov 1, 2013, 00:00

  • Haemophilia A- Annual Cost Comparison Between FL-rFVIII and BDD-rFVIII in Fran We Should Compare the Cost Per Patient Instead of the Price Per Unit

    Nov 1, 2013, 00:00

  • Economic Evaluation of Mandibular Advancement Device to Treat Obstructive Sleep Apnea

    Nov 1, 2013, 00:00

  • Issues with Cost-Effectiveness Modelling of Diagnostic Tests – Case Study of Ischaemic Cardiomyopathy

    Nov 1, 2013, 00:00

  • Using Feedback from Patients in Determining Suitability of the Perceived Deficits Questionnaire (PDQ) and the Resource Utilization in Dementia-Lite (RUD-Lite) for Use in Clinical Trials in Prodromal Alzheimer’s Disease

    Nov 1, 2013, 00:00

  • Predictor Factors for the Presence of Post Herpetic Neuralgia at 3 Months in Herpes Zoster Patients Aged 50 and Over in Italy- Results from a Gp-Based Observational Prospective Multicenter Study

    Nov 1, 2013, 00:00

  • Managed Entry Agreements and Orphan Drugs- A European Comparative Study (2006-2012)

    Nov 1, 2013, 00:00

  • Reasons Given by the European Medicines Agency for Revising Disease-Specific Scientific Guidelines

    Nov 1, 2013, 00:00

  • Key Drivers of Pbac Decisions for the Reimbursement of Orphan Drugs on the Life Saving Drugs Program

    Nov 1, 2013, 00:00

  • Reanalyzing Using Bayesian Methods and Updated Data the Cost-Efectiveness Assumptions of Carotid Artery Stenosis Treatments

    Nov 1, 2013, 00:00

  • Toxocariasis- A Disease of High Prevalence But Forgotten

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Renal Post-Transplant Prophylaxis with Belatacept in Colombia

    Nov 1, 2013, 00:00

  • Desarrollo De Una Escala De Estructuras Y Proceso Para La Evaluación De Los Centros De Hemodiálisis

    Nov 1, 2013, 00:00

  • Re-Engineering of the Distribution of Drugs in the Hospital. TOC Application and TRZ

    Nov 1, 2013, 00:00

  • A Mediação De Conflitos Na Ação Fiscalizatoria Do Setor De Saúde Suplementar Brasileiro

    Nov 1, 2013, 00:00

  • The Costs of Managing Genital Warts in the UK by Devolved Nation- England, Scotland, Wales and Northern Ireland

    Nov 1, 2013, 00:00

  • Study and Evaluation of Medication Errors in Diabetic Patients in Medicine Ward of a Secondary Care Community Hospital at Mumbai, India

    Nov 1, 2013, 00:00

  • Aflibercept + FOLFIRI (AF) Versus. Placebo + FOLFIRI (PF) in Metastatic Colorectal Cancer (mCRC)- Mean Overall Survival (OS) in a “Better Responders” Patient Population of the Velour Trial

    Nov 1, 2013, 00:00

  • A Lei De Acesso À Informação Fortalece O Papel Da Avaliação De Tecnologias Em Saúde (ATS) De Fornecer Informações Sólidas E Transparentes Aos Usuários Do Sistema Único De Saúde

    Nov 1, 2013, 00:00

  • Examining the Burden of Illness of Veteran Patients Diagnosed with Obesity in the United States

    Nov 1, 2013, 00:00

  • Patients with Hypertension in Primary Care in Spain- Management, Self-Perception and Satisfaction

    Nov 1, 2013, 00:00

  • Avaliação Do Impacto Orçamentário Com a Incorporação De Imunobiológicos Em Uma Operadora De Planos De Saúde – 2012

    Nov 1, 2013, 00:00

  • Economic Impact of the Use of an Absorbable Adhesion Barrier in Preventing Adhesions Following Open Gynecologic Surgeries

    Nov 1, 2013, 00:00

  • The Potential of a Reduction in the Risk of Opioid-Related Fractures to Drive the Cost-Effectivness of an Analgesic

    Nov 1, 2013, 00:00

  • Does Personalised Health Care (PHC) in Oncology Require New Approaches to Clinical Development, Regulatory Assessment, and Economic Evaluation?

    Nov 1, 2013, 00:00

  • A Proposed 6-Item Reduction for the European Organization for the Research and Treatment of Cancer-Quality of Core Questionnaire (EORTC QLQ-C30) - Cuban Group of Trialists on Epidermal Growth Factor (CGT-EGF)

    Nov 1, 2013, 00:00

  • Changes in Patient-Reported Outcomes Among Pediatric Leukemia and Lymphoma Patients During the First 2-Years Post Allogeneic Stem Cell Transplantation (alloSCT)

    Nov 1, 2013, 00:00

  • Measurements of Adherence to Oral Therapies Among Brazilian Patients- A Systematic Review

    Nov 1, 2013, 00:00

  • Comparing Costs and Consequences of Treating Chronic Obstructive Pulmonary Disease with Budesonide/Formoterol and Fluticasone/Salmeterol

    Nov 1, 2013, 00:00

  • How Should an Antidepressant with Reduced Risk of Sexual Dysfunction Be Positioned in Treatment Strategies for Patients with Major Depressive Disorder?

    Nov 1, 2013, 00:00

  • Developing a Population-Based Dementia Registry Focusing on Patients and Carer Needs- Methodological Challenges

    Nov 1, 2013, 00:00

  • Use of Beta Blocking Agents in Serbia in the Period from 2007 to 2011 Year

    Nov 1, 2013, 00:00

  • Atrial Fibrillation’s Burden of Disease in Portugal

    Nov 1, 2013, 00:00

  • Efficacy and Tolerability of CT-Guided Epidural Steroid Injections and Pharmacotherapy for Managing Chronic Low Back Ache with Radiculopathy

    Nov 1, 2013, 00:00

  • Investigating the Impact of Mental Health Status on Health and Social Care Costs of Older People after Acute Hospital Admission

    Nov 1, 2013, 00:00

  • Cost-Minimization Analysis of Subcutaneous Abatacept in the Treatment of Rheumatoid Arthritis in Spain

    Nov 1, 2013, 00:00

  • Health and Social Care Resource Use by Individuals with Fragile X Syndrome- Results of Two Delphi Panels

    Nov 1, 2013, 00:00

  • Predicting Health Care Costs in Asthma Using the EQ-5D Index Score

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Dapagliflozin (Forxiga®) Versus Insulin in the Treatment of Type 2 Diabetes Mellitus (T2DM) in England and Wales

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Transcatheter Aortic-Valve Implantation for Severe Symptomatic Aortic Stenosis in Inoperable Patients in the Brazilian Public Health Care System

    Nov 1, 2013, 00:00

  • Cost Per Cure of Telaprevir and Boceprevir in Treatment-Naïve Genotype 1 Hepatitis C Patients with F2 Fibrosis in Brazil

    Nov 1, 2013, 00:00

  • Potential Predictors of Alzheimer’s Disease- An Analysis with the Quebec Provincial Drug Reimbursement Program Database

    Nov 1, 2013, 00:00

  • Hepatitis a Vaccine Policy Process in 6 Countries – Factors Influencing Potential Adoption

    Nov 1, 2013, 00:00

  • Network Meta-Analysis of Multiple Outcomes- A Simulation Study and Application

    Nov 1, 2013, 00:00

  • Simulated Treatment Comparisons – An Alternative Approach to Indirect Comparison When Standard Methods Are Not Feasible or Appropriate

    Nov 1, 2013, 00:00

  • Psychometric Properties of the Hypoglycemia Perspectives Questionnaire (HPQ) in Type 2 Diabetes Mellitus

    Nov 1, 2013, 00:00

  • Improvements in Physical Function, Health Related Quality of Life and Work Productivity in Patients with Rheumatoid Arthritis Treated with Golimumab- Sub-Analysis of Latin American Patients Enrolled in Mulitcentre Phase III Clinical Trials

    Nov 1, 2013, 00:00

  • Persistence Patterns with Oral Hypoglycaemic Medicines (OHM) in Newly Treated Irish Patients with Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2013, 00:00

  • Budget Impact of Switching from an Immediate-Release to a Prolonged-Release Formulation of Tacrolimus in Renal Transplant Recipients in the UK Based on Differences in Adherence

    Nov 1, 2013, 00:00

  • Two Simple Methods of Measuring Adherence in Hypertensive Patients Are Predictive of Blood Pressure Control- Pooled Analysis of 17,516 Patients from Seven Valsartan Studies

    Nov 1, 2013, 00:00

  • Medical and Pharmacy Claims-Based Algorithms for Identifying Relapses in Patients with Multiple Sclerosis

    Nov 1, 2013, 00:00

  • Utility Values for Patients with Advanced Gastrointestinal Stromal Tumors (GIST) Treated with Regorafenib Versus Placebo in the Phase III Grid Trial

    Nov 1, 2013, 00:00

  • Systematic Review Comparing the Efficacy and Safety of Collagenase Clostridium Histolyticum (Xiaflex®) Injection with Surgical Fasciectomy for the Treatment of Dupuytren’s Contracture

    Nov 1, 2013, 00:00

  • Impact of Exclusive Hospital Distribution of Biosimilar on Drug Health Care Budget

    Nov 1, 2013, 00:00

  • Costos Económicos Asociados A Secuelas De Meningitis En Colombia

    Nov 1, 2013, 00:00

  • A Cost-Effectiveness Analyses of Using Sunitinib (SU) in First Line of Metastatic Renal Cancer in Romanian Jurisdiction

    Nov 1, 2013, 00:00

  • Estudio Transversal Del Proceso De Actualización De Medicamentos En El Cuadro Básico Y Catálogo De Insumos Del Sector Salud

    Nov 1, 2013, 00:00

  • Direct Medical Costs (DMC) of Treating Chronic Lymphoid Leukemia (CLL) Patients in the Private Health Care System in Brazil- Results from a 12-Month Retrospective Analysis of an Administrative Database

    Nov 1, 2013, 00:00

  • Comprehensive Overview- Efficacy, Tolerability and Cost- Effectiveness of Irbesartan

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Antimicrobials as Treatment for Patients with Complicated Skin and Soft Tissues Infections- A Comparison Between Ceftaroline, Linezolid and Vancomycin in the Russian Health Care

    Nov 1, 2013, 00:00

  • Building a Real World Practice-Based Network Data Platform to Link Rare Disease Patients- Case Study of Myelofibrosis Patients in the United States

    Nov 1, 2013, 00:00

  • Bayesian Network Meta-Analysis to Assess the Relative Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled on Metformin and Sulphonylurea (MET+SU)

    Nov 1, 2013, 00:00

  • Systematic Review- The Economic Burden of Crohn’s Disease in Europe in Adults and Children

    Nov 1, 2013, 00:00

  • Systematic Review of Patient Reported Outcomes in Chronic Myeloid Leukemia

    Nov 1, 2013, 00:00

  • Medication Treatment and Health Care Utilization for Attention-Deficit/Hyperactivity Disorder (ADHD) in Germany

    Nov 1, 2013, 00:00

  • Health-Related Quality of Life (HRQL) in Chronic Hepatitis C (CH-C) Patients Treated with Sofosbuvir Containing Interferon-Free Regimens

    Nov 1, 2013, 00:00

  • Resource Use and Disease Progression Among HCV-Positive Patients

    Nov 1, 2013, 00:00

  • Calibration of a Cost-Effectiveness Model to Evaluate the Incorporation of a Quadrivalent HPV Types 6, 11, 16, 18 Vaccine in Argentina- Disease Burden Component

    Nov 1, 2013, 00:00

  • Direct Medical Costs of Treating Diabetes-Related Complications in Argentina

    Nov 1, 2013, 00:00

  • Use of the French Claims and Hospitalisations Database to Estimate the Prevalence and Incidence of Parkinson’s Disease in France

    Nov 1, 2013, 00:00

  • Future Costs Inclusion in Published Economic Evaluations- What Is the Current Situation?

    Nov 1, 2013, 00:00

  • Importance of Subgroup Analyses for Health Technology Assessments

    Nov 1, 2013, 00:00

  • IQWIG’s Efficiency Frontier Approach- Fit for Purpose!

    Nov 1, 2013, 00:00

  • Cost of Cancer in the Austrian Hospital Setting

    Nov 1, 2013, 00:00

  • Patients’ Characteristics and Patterns of Use of Depot Antipsychotics in German Patients with Schizophrenia

    Nov 1, 2013, 00:00

  • Consumption Patterns, Market Characteristics and Regulation in the Pharmaceutical Industry- Evidence from Two Therapeutic Groups in Insured Population in Argentina

    Nov 1, 2013, 00:00

  • Quality of Life (QOL) and Resources Consumption in Insulin-Dependent Diabetic Patients with A1CNOW+ and CONTOUR USB. Comet Study

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of a Vaccination Programme for the Prevention of Herpes Zoster and Post-Herpetic Neuralgia in Adults Aged 50 and Over in Germany

    Nov 1, 2013, 00:00

  • Unmet Health Needs of Immigrants Living in Greece During the Economic Crisis- The Long-Term Impact for the Health Care System

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Bendamustine Versus Fludarabine for the First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) in Mexico

    Nov 1, 2013, 00:00

  • Medición De La Calidad De Vida Por Medio Del “Dermatology Life Quality Index” En Pacientes Con Psoriasis- Una Revisión Sistemática

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Anti-Rabies Prophylaxis After Exposure to Unobservable Dogs in Eradication Context- The French Case

    Nov 1, 2013, 00:00

  • Comparative Effectiveness of Active Versus Sham Acupuncture Versus Usual Care in the Management of Chronic, Non-Cancer Pain in Primary Care

    Nov 1, 2013, 00:00

  • Health Care Costs Associated with Chronic Hepatitis C Infection in Europe

    Nov 1, 2013, 00:00

  • The Geographic Correlation Between Lyme Disease Incidence and Degenerative Neurological Disease Mortality- An Ecological Study

    Nov 1, 2013, 00:00

  • Cost Analysis of Proton Pump Inhibitors in the Treatment of Ulcer Duodenum in Ukraine

    Nov 1, 2013, 00:00

  • Analysis of Published Health Technology Assessments (HTA) in Russia and Its Place in Russian Reimbursement System

    Nov 1, 2013, 00:00

  • The Importance of Sensitivity Analyses in Health Technology Assessments

    Nov 1, 2013, 00:00

  • Exploratory Structural Equation Models- A Simulation Study Exploring Geomin and Target Rotation Techniques on Variations of ESEM Models

    Nov 1, 2013, 00:00

  • Projeção De Gastos Com Medicamentos De Uso Crônico (Ambulatorial)

    Nov 1, 2013, 00:00

  • 2.5 YEARS OF AMNOG IN GERMANY – AN ANALYSIS OF BENEFIT ASSESSMENT AND NET PRICE NEGOTIATION TRENDS

    Nov 1, 2013, 00:00

  • Dealing with Zero Cells in Sparse Networks in Bayesian Network Meta-Analysis

    Nov 1, 2013, 00:00

  • Health Care Resource Use and Direct Costs Associated with Fragile X Syndrome (FXS) in the United States

    Nov 1, 2013, 00:00

  • Assessing Quality of Life in Adult Growth Hormone Deficiency- Further Development of the QoL-AGHDA

    Nov 1, 2013, 00:00

  • The Impact of Chlamydia and Gonorrhoea Point of Care Nucleic Acid Amplification Tests on Clinical Pathways and Costs in Genito-Urinary Medicine Clinics in the United Kingdom

    Nov 1, 2013, 00:00

  • Continued Improvements in Workplace and Household Productivity with Certolizumab Pegol Treatment in Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis- 48-Week Results from the Rapid-axSpA ...

    Nov 1, 2013, 00:00

  • Frecuencia Y Costos De Hospitalización En Una Población De Pacientes En Dialisis En Colombia

    Nov 1, 2013, 00:00

  • Use of Surrogate Outcomes in Health Technology Assessments (HTAs)

    Nov 1, 2013, 00:00

  • Adherence to Disease-Specific Recommendations for Pharmacoeconomic Studies in Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • A Study of A. Baumannii in a Tertiary Care Hospital with Consideration to Risk Factors of Infection and Resistance Pattern

    Nov 1, 2013, 00:00

  • Health-Related Quality of Life (HRQoL) in Patients Treated by Novel Oral Anticoagulants (NOACs)- Reduced Version of the Sawicki Questionnaire

    Nov 1, 2013, 00:00

  • Breast Cancer Screening Program in the Basque Country- Costs and Health Benefits Assessment Through Discrete Event Simulation

    Nov 1, 2013, 00:00

  • The Role of Half-Cycle Correction in the Models Used for Health Technology Assessment

    Nov 1, 2013, 00:00

  • Mood Stabilizers and Atypical Antipsychotics in Maintenance Therapy for Bipolar Disorder- A Cost-Effectiveness Analysis

    Nov 1, 2013, 00:00

  • Evaluation of Home Medication Review in Community Out Reach Program

    Nov 1, 2013, 00:00

  • Active-Implantable Cardiac Devices- Is There Room for Cost Savings in Portuguese Hospitals?

    Nov 1, 2013, 00:00

  • The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life

    Nov 1, 2013, 00:00

  • Exploring the Key Decision Drivers Provided by HTA Agencies Accepting Submissions with ICERs Higher Than the Threshold

    Nov 1, 2013, 00:00

  • Economic Evaluation of Apixaban for the Prevention of Stroke in Atrial Fibrillation in the Netherlands

    Nov 1, 2013, 00:00

  • Cost-Minimization Analysis of Multifocal and Monofocal Intraocular Lenses in Cataract Surgery in the Czech Republic

    Nov 1, 2013, 00:00

  • The Framework for Health Economic Modeling and Multi-Criteria Decision Analysis (MCDA) on the Example of the Mobile Stroke Unit (MSU)

    Nov 1, 2013, 00:00

  • Pharmacists’ Satisfaction with Different Pharmaceutical Distribution Models in Five European Countries

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Diferent Anti-Parkinsonian Drugs Used in Monopherapy During Early Stages of Parkinson Disease

    Nov 1, 2013, 00:00

  • Efficacy of Brentuximab Vedotin and Other Treatments in Patients with Relapsed or Refractory (RR) Systemic Anaplastic Large-Cell Lymphoma (SALCL)- A Systematic Review

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Basiliximab As Induction Therapy for Kidney Transplantation in Mexico

    Nov 1, 2013, 00:00

  • Bayesian Evidence Synthesis of Safety Data- A Robust Option?

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Incorporation of the HPV Vaccine to the National Immunization Program / NIP of Brazil

    Nov 1, 2013, 00:00

  • Estimating the Impact of Statin Therapy on Direct and Societal Costs in Mexico- A Comparison to Sweden

    Nov 1, 2013, 00:00

  • Early-Stage Economic Evaluation of Stratified Medicine in Multiple Myeloma

    Nov 1, 2013, 00:00
  • «
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117 (current)
  • 118
  • 119
  • 120
  • »